CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- S-1 Offering Registration Statement
- 424B2 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- F-3 Offering F-3
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 4 Insider Changes in Ownership
- 4 Open-market buy 10% owner bought 20,100 shares at an average $5.03 ($101,130)
- 4 Open-market buy 10% owner bought 2,575 shares at an average $5.35 ($13,788)
- 4 Open-market buy 10% owner bought 68,404 shares at an average $5.59 ($382,520)
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 424B3 Offering Prospectus
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- 4 Open-market buy 10% owner bought 28,207 shares at an average $6.22 ($175,534)
Page 33 of 38 · 746 filings